Editorial Policy | Paper Types and Copyright | Word Count | Preparation of Manuscripts | ORCID IDs |References | Tables | Figures | Permissions | Journal Style | Required Statements | Cambridge Open | Author Language Services
Expert Reviews in Molecular Medicine is an innovative online journal featuring authoritative and timely Reviews that bring a new emphasis on translational aspects of molecular medicine, including those related to the application of discoveries in the molecular basis of disease to clinical practice and experimental medicine will be viewed as important for development.
Areas covered include but are not limited to:
Submission of a paper will be taken to imply that it is unpublished and it is not being considered for publication elsewhere.
Paper Types and Copyright
Reviews will be published at no charge to the author under a standard copyright transfer agreement, unless the author elects to publish their paper under an open access licence (see Cambridge Open section below for more details). The article processing charge is currently £1870 / $2980.
Reviews should aim to provide both an interesting introduction to the area for a wide readership and an authoritative, insightful and up-to-date summary for researchers in the field. Write in a clear and accessible but scholarly style, using informative figures to aid understanding and tables to collate findings.
The length of the article will depend on the scope of the subject area and its topicality, and both broad reviews and shorter, more focused overviews are published in the journal. The article should aim not to exceed 6,000 words for the main text, and 150 references.
Preparation of Manuscripts
The title should be short but informative, and accurately reflect the content.
Authors and contact details
Authors should meet each of the following requirements by substantial contributions to '(a) the conception and design, acquisition of data, or analysis and interpretation of data; (b) the drafting the article or revising it critically for important intellectual content.’ All authors must have approved the final version of the manuscript submitted. The contribution of individuals who were involved in the study but do not meet these criteria should be acknowledged in the Acknowledgments section.
List a brief affiliation for each author (assigned with superscript numbers) below the author names on the title page; in addition, indicate the corresponding author with an asterisk and in this case provide a full postal address and email. Please note that the submission will appear only in the folder of the person designated as corresponding author. Other authors will be unable to view/approve or follow its progress online.
The abstract should introduce and describe the main points of the article in under 200 words. References should not be included. Emphasise the clinical implications of the subject area.
Please supply 5-10 keywords to help others search for your paper.
Ensure sufficient background is included at the start of the review, so that it is accessible to a wide readership; the target audience includes researchers and clinicians from various disciplines, and undergraduate and postgraduate students of biomedical sciences and their educators. Technical terms and concepts specific to your subject area should be briefly defined or explained. Depending on the topic, a brief historical perspective and indication of current issues and aims in the field might be helpful.
The use of informative subheadings (three levels of subheadings can be used) is encouraged, as well as using tables and figures to summarise findings.
If not discussed throughout the article, a separate section should be included where the major clinical trials, both completed and ongoing, are described.
Research in progress and outstanding research questions
If not discussed throughout the article, a separate section should be included which can include unanswered questions in the field of research, or the ethical/clinical issues associated with them. A discussion on how they can be addressed, and what are the existing and/or likely future barriers to doing so as well as a discussion on the most interesting and innovative approaches being used in current research is encouraged.
Additional material (e.g. data sets, large tables) relevant to the paper can be submitted with your manuscript for publication online, where they are made available via a link from the paper. The paper should stand alone without these data. Supplementary Material must be cited in a relevant place in the text of the paper and must be submitted as a separate file.
Please note that captions or legends should be included for all figures and tables in Supplementary Material. You should number figures or tables with the prefix 'S', e.g. Supplementary Figure S1, Supplementary Table S1. Although Supplementary Material is peer reviewed, it is not checked, copyedited or typeset after acceptance and it is loaded onto the journal's website exactly as supplied. You should check your Supplementary Material carefully to ensure that it adheres to journal styles. Corrections cannot be made to the Supplementary Material after acceptance of the manuscript. Please bear this in mind when deciding what content to include as Supplementary Material.
Expert Reviews in Molecular Medicine now requires that all corresponding authors identify themselves using ORCID when submitting a manuscript to the journal. Joining ORCID is fast, free and you do not need to have a current affiliation. ORCID provides a unique identifier for researchers and, through integration in key research workflows such as publication and grant applications, provides the following benefits:
- Discoverability: ORCID increases the discoverability of your publications, by enabling smarter publisher systems and by helping readers to reliably find work that you’ve authored.
- Convenience: As more organisations use ORCID, providing your ID or using it to register for services will automatically link activities to your ORCID profile, and will save you re-keying information multiple times.
- Keeping track: Your ORCID profile is a neat place to record and display (if you choose) validated information about your research activities.
If you don’t already have an ID, you’ll need to create one if you decide to submit a manuscript to Expert Reviews in Molecular Medicine. You can register for one directly from your user account on ScholarOne or Editorial Manager or via https://orcid.org/register. If you already have an ID, please use this when submitting by linking it to your Editorial Manager user account. Simply log in to your account using your normal username and password. Edit your account by clicking on your name at the top right of the screen and from the dropdown menu, select 'E-Mail / Name'. Follow the instructions at the top of the screen to update your account.
For more information read this.
Please try to keep the number of references to fewer than 150 for review papers. Number references consecutively in the order in which they are first mentioned in the text. Identify references in text, tables and legends by Arabic numerals in square brackets (not superscript numbers). References cited only in tables or in legends to figures should be numbered in accordance with a sequence established by the first identification in the text of the particular table or illustration.
Chen Z., de Freitas L.B. and Burk R.D. (2015) Evolution and classification of oncogenic human papillomavirus types and variants associated with cervical cancer. Methods in Molecular Biology 1249, 3-26.
Xu B.et al. (2013) Multiplex identification of human papillo-mavirus 16 DNA integration sites in cervical carcinomas. PLoS ONE 8, e66693
Okpaku SO. Essentials of Global Mental Health. Cambridge: Cambridge University Press, 2014, pp. 56.
Fotiadis D.I. (2016) HPV Detection Methods, Handbook of Research on Trends in the Diagnosis and Treatment of Chronic Conditions, IGI Global, Hershey, Pennsylvania, USA, pp. 99-132
The top 10 causes of death. http://www.who.int/media-centre/factsheets/fs310/en/ Accessed on November 2016
Tables should have a simple title. Use lowercase letters to refer to footnotes, and list these alphabetically below the table. Abbreviations used should be defined in a list below the table, in alphabetical order. References cited in the table should be included in the reference list. Either include tables at the end of the same Word document as the main text or as separate files. These need to be in an editable format and not as PDFs.
Please consider carefully which aspects of your review would benefit most from supporting figures, and include informative diagrams or photographic images with your article. Figures will be reproduced as supplied.
Use a simple title, and a self- standing figure legend that explains the figure in detail and defines all abbreviations used (even if already given in the main text). Use 'a', 'b', 'c' etc. to refer to different parts of the figure.
Error bars should be shown and defined, and statistical tests should also be defined for each figure.
If you need to include textual or illustrative material not in your copyright and not covered by fair use or fair dealing, permission must be obtained from the relevant publisher for the nonexclusive right to reproduce the material in all forms and media, including electronic publication. This can be done after acceptance of your article, and then correspondence showing permission has been granted should be forwarded to the editorial office with the revised article.
Clinical photos revealing patient identity should be avoided; in cases where this is not possible, patient consent must be obtained.
- English (UK) is the standard for spellings, but US spellings may be used where required in the reference list (e.g. article titles).
- Abbreviations should be defined in full at first mention in the text.
- For human gene names, use style given by the HUGO Gene Nomenclature Committee.
For gene nomenclature in other species, please refer to appropriate organism-specific databases, such as Mouse Genome Informatics
- For GPCRs and ion channels use style in International Union of Basic and Clinical Pharmacology databases. For diseases, use UK spelling of names in Online Mendelian Inheritance in Man; for drug names use style in the British National Formulary; for viruses refer to the database of the International Committee on Taxonomy of viruses.
Contributors should note the following:
The four sections below must be included in all papers. These statements should be included in the front page, which should be uploaded separately to the main text of the article.
You may acknowledge individuals or organisations that provided advice, support (non-financial). Formal financial support and funding should be listed in the following section.
Please provide details of the sources of financial support for all authors, including grant numbers. For example, "This work was supported by the Medical research Council (grant number XXXXXXX)". Multiple grant numbers should be separated by a comma and space, and where research was funded by more than one agency the different agencies should be separated by a semi-colon, with 'and' before the final funder. Grants held by different authors should be identified as belonging to individual authors by the authors' initials. For example, "This work was supported by the Wellcome Trust (A.B., grant numbers XXXX, YYYY), (C.D., grant number ZZZZ); the Natural Environment Research Council (E.F., grant number FFFF); and the National Institutes of Health (A.B., grant number GGGG), (E.F., grant number HHHH)". Where no specific funding has been provided for research, please provide the following statement: "This research received no specific grant from any funding agency, commercial or not-for-profit sectors."
Conflict of interest
Please provide details of all known financial, professional and personal relationships with the potential to bias the work. Where no known conflicts of interest exist, please include the following statement: "None."
Where research involves human and/or animal experimentation, the following statements should be included (as applicable): "The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008." and "The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional guides on the care and use of laboratory animals."Publication Ethics
Please visit https://www.cambridge.org/core... for information on our ethical guidelines.
Authors also have the option to publish their paper under a fully 'Open Access' agreement, upon the payment of a one-off 'Article Processing Charge'. In this case, the final published 'Version of Record' shall be made freely available to all, in perpetuity, and will be published under a creative commons licence, enabling its free re-use and redistribution for non-commercial means. The corresponding author will be able to choose between standard publication and publication under the 'Open Access' agreement once their paper has been accepted.
Author Language Services
Cambridge recommends that authors have their manuscripts checked by an English language native speaker before submission; this will ensure that submissions are judged at peer review exclusively on academic merit. We list a number of third-party services specialising in language editing and/or translation, and suggest that authors contact as appropriate. Use of any of these services is voluntary, and at the author's own expense.